Plasmid DNA Manufacturing Market, By Grade, By Development Phase (Pre-Clinical Therapeutics, Marketed Therapeutics and Clinical Therapeutics), By Application, By Disease, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV2053
|
Published Date
August 2026
|
Pages
287
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Plasmid DNA Manufacturing Market size was valued at US$ 2,478.52 Million in 2025, expanding at a CAGR of 17.98% from 2026 to 2033.
Plasmid DNA Manufacturing means the production of plasmids, which are DNA molecules in the form of circles of double-stranded DNA, by means of controlled biological and purification processes. Plasmid DNA is mostly produced for gene therapy, DNA vaccination, cell and gene therapy, recombinant proteins, and another research. The process of plasmid DNA manufacturing includes plasmid design and cloning, transformation of bacteria such as Escherichia coli and fermentation to increase the number of plasmids, harvesting, cell lysis, DNA purification, and testing and quality control. However, for clinical and commercial application, the process of manufacturing is carried out under GMP conditions to ensure compliance with the needed quality of the produced plasmid DNA.
Plasmid DNA Manufacturing Market- Market Dynamics
Growing gene and cell therapy pipeline drives market growth
The rapid expansion of gene and cell therapy pipelines is a major driver for the plasmid DNA manufacturing market. Plasmid DNA is an essential component in the manufacturing process of several viral vectors, including AAV and lentiviral vectors and is also used directly in some gene therapies. By the end of 2024, the gene-therapy pipeline contained approximately 1,424 preclinical candidates, 341 Phase I candidates, 306 Phase II candidates, and 35 Phase III candidates, suggesting there is a large pool of programs that will be entering clinical and commercial manufacturing, according to the Cogentia. As these therapies progress through the clinical phases, developers require increasing quantities of high-quality and GMP-grade plasmid DNA.
Leading pipeline programs in 2025 will be important drivers for the plasmid DNA manufacturing market. Vertex Pharmaceuticals's CASGEVY (exagamglogene autotemcel) is a major gene-editing therapy, while Sarepta Therapeutics's ELEVIDYS (delandistrogene moxeparvovec) represents a commercial AAV-based therapy; both are included in the FDA's list of approved cellular and gene therapy products. As such therapies continue to progress, there will be downstream requirements for plasmid DNA for use in the manufacturing process of viral vectors.
Plasmid DNA Manufacturing Market- Segmentation Analysis:
The Global Plasmid DNA Manufacturing Market is segmented on the basis of grade, development phase, application, disease, and Region.
The market is divided into three categories based on development phase: Pre-Clinical Therapeutics, Marketed Therapeutics and Clinical Therapeutics. The Clinical Therapeutics sector is expected to observe significant revenue growth in the Plasmid DNA Manufacturing market. The strong revenue outlook of the segment is primarily attributed to the rising number of therapeutic candidates entering pre-clinical development and subsequently progressing towards phase I-III clinical trials. Clinical grade plasmids, which are used in the manufacturing process of gene therapies, are increasingly in demand in connection with the production of viral vectors, gene-editing, or as a direct therapeutic moiety. The greater need for plasmid DNA of higher quality and compliance (GMP) is also linked to the greater need for consistent and large-scale production of plasmids for use in later-stage clinical trials.
The market is divided into four categories based on disease: Genetic Disorder, Cancer, Infectious Disease and Others. The Cancer segment would witness the highest revenue growth. The significant revenue growth is driven by the rising adoption of plasmid DNA in cancer gene treatments, cell therapies, viral-vector production and DNA-based cancer vaccinations. Plasmid DNA is a key starting material for the production of viral vectors and for the genetic modification of cells utilized in modern oncology therapies. The demand for high-purity and GMP-grade plasmid DNA is being driven by the growth of gene and cell therapy pipelines in the cancer area by pharmaceutical and biotechnology companies, especially as candidates move from pre-clinical research to clinical and commercial manufacture. This demand is also being fueled by rising use of tailored and targeted cancer medicines.
Plasmid DNA Manufacturing Market- Geographical Insights
North America dominates the market. One of the major growth drivers is the high and increasing cancer burden and growing interest in gene treatments, cell therapies, cancer vaccines and other novel biotherapeutics that use plasmid DNA as a critical input in their production process. In 2025, the National Cancer Institute estimates there will be 2,041,910 new cancer cases and 618,120 cancer deaths in the United States. Meanwhile, Canadian Cancer Statistics predicts that there will be 254,800 new cancer cases and 87,400 cancer deaths in Canada in 2025. This huge cancer burden is making pharmaceutical and biotech companies to ramp up their oncology focused gene and cell therapy pipeline which in turn is driving the requirement for high purity and GMP-grade plasmid DNA for manufacturing viral vectors and genetic engineering.
US Plasmid DNA Manufacturing Market- Country Insights
The US holds a majority of market share. One of the major drivers for this growth is the huge investment made by the leading pharmaceutical and biotech companies in development and manufacturing of gene and cell therapy which is leading to an increasing demand for high-quality plasmid DNA as a critical component in the production of viral vectors and genetic engineering. For instance, Novartis announced in April 2025 that it would invest $23 billion over five years in its U.S. manufacturing and research and development footprint including expanding capabilities supporting advanced therapies. Its U.S. network already includes a gene-therapy manufacturing facility in Durham, North Carolina.
Plasmid DNA Manufacturing Market- Competitive Landscape:
Plasmid DNA manufacturing market is moderately consolidated with several key players and highly competitive, with competition focused on GMP manufacturing capacity, scale, quality of products, regulatory know-how, turn around time and end-to-end services. Key players include Charles River Laboratories, Danaher (Aldevron), Lonza, Thermo Fisher Scientific, GenScript ProBio, VGXI, Catalent, AGC Biologics, WuXi AppTec, Eurogentec, Kaneka, VectorBuilder.
Recent Developments:
- In August 2026, 4basebio PLC, a specialist in enzymatically-produced, cell-free DNA for new genetic medicines, and Genezen, a best-in-class viral vector contract development and manufacturing organization (CDMO), announced an expanded, non-exclusive collaboration providing drug developers access to 4basebio's Research Use Only, High-Quality, and GMP-grade hpDNA® development and clinical programs. Through the collaboration, Genezen will offer access to 4basebio's synthetic DNA developed specifically for viral vector applications, creating a more streamlined path for cell and gene therapy developers to advance programs toward the clinic.
- In January 2026, Bionova Scientific LLC, an Asahi Kasei company and a bespoke CDMO, has announced a strategic manufacturing alliance with Syenex, a genetic medicines platform company. The collaboration is focused on expanding global access to plasmid DNA used in next-generation gene delivery for advanced cell and gene therapies. Under the agreement, Bionova Scientific will serve as the preferred manufacturing partner for Syenex’s delivery platforms. The partnership builds on Bionova’s plasmid DNA manufacturing capabilities, which support lentiviral vector production and DNA templates for mRNA manufacturing. The companies said the alliance addresses ongoing challenges in pricing, quality, and supply-chain reliability of plasmid DNA.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PLASMID DNA MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Lonza
- Charles River Laboratories
- Thermo Fisher Scientific
- AGC Biologics
- GenScript ProBio
- Aldevron (Danaher)
- Cobra Biologics (Charles River)
- Catalent
- WuXi AppTec
- WuXi Advanced Therapies
- Eurogentec
- Sartorius (BIA Separations)
- PharmaCell
- ProBio
- Pharmaron
- Esco Aster
- AGTC (Applied Genetic Technologies Corp.)
- VGXI (GeneOne Life Science)
- PlasmidFactory
- VectorBuilder
- Others
GLOBAL PLASMID DNA MANUFACTURING MARKET, BY GRADE- MARKET ANALYSIS, 2020 - 2033
- R&D Grade
- Viral Vector Development
- AAV
- Lentivirus
- Adenovirus
- Retrovirus
- Others
- mRNA Development
- Antibody Development
- DNA Vaccine Development
- Others
- GMP Grade
GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DEVELOPMENT PHASE- MARKET ANALYSIS, 2020 - 2033
- Pre-Clinical Therapeutics
- Marketed Therapeutics
- Clinical Therapeutics
GLOBAL PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- DNA Vaccines
- Immunotherapy
- Cell & Gene Therapy
- Others
GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DISEASE- MARKET ANALYSIS, 2020 - 2033
- Genetic Disorder
- Cancer
- Infectious Disease
- Others
GLOBAL PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENTS
1. Plasmid DNA Manufacturing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Plasmid DNA Manufacturing Market Snippet by Grade
2.1.2. Plasmid DNA Manufacturing Market Snippet by Development Phase
2.1.3. Plasmid DNA Manufacturing Market Snippet by Application
2.1.4. Plasmid DNA Manufacturing Market Snippet by Disease
2.1.5. Plasmid DNA Manufacturing Market Snippet by Country
2.1.6. Plasmid DNA Manufacturing Market Snippet by Region
2.2. Competitive Insights
3. Plasmid DNA Manufacturing Key Market Trends
3.1. Plasmid DNA Manufacturing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Plasmid DNA Manufacturing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Plasmid DNA Manufacturing Market Opportunities
3.4. Plasmid DNA Manufacturing Market Future Trends
4. Plasmid DNA Manufacturing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Plasmid DNA Manufacturing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Plasmid DNA Manufacturing Market Landscape
6.1. Plasmid DNA Manufacturing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Plasmid DNA Manufacturing Market – By Grade
7.1. Overview
7.1.1. Segment Share Analysis, By Grade, 2025 & 2033 (%)
7.1.2. R&D Grade
7.1.2.1. Viral Vector Development
7.1.2.1.1. AAV
7.1.2.1.2. Lentivirus
7.1.2.1.3. Adenovirus
7.1.2.1.4. Retrovirus
7.1.2.1.5. Others
7.1.2.2. mRNA Development
7.1.2.3. Antibody Development
7.1.2.4. DNA Vaccine Development
7.1.2.5. Others
7.1.3. GMP Grade
8. Plasmid DNA Manufacturing Market – By Development Phase
8.1. Overview
8.1.1. Segment Share Analysis, By Development Phase, 2025 & 2033 (%)
8.1.2. Pre-Clinical Therapeutics
8.1.3. Marketed Therapeutics
8.1.4. Clinical Therapeutics
9. Plasmid DNA Manufacturing Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
9.1.2. DNA Vaccines
9.1.3. Immunotherapy
9.1.4. Cell & Gene Therapy
9.1.5. Others
10. Plasmid DNA Manufacturing Market – By Disease
10.1. Overview
10.1.1. Segment Share Analysis, By Disease, 2025 & 2033 (%)
10.1.2. Genetic Disorder
10.1.3. Cancer
10.1.4. Infectious Disease
10.1.5. Others
11. Plasmid DNA Manufacturing Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Plasmid DNA Manufacturing Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Plasmid DNA Manufacturing Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Plasmid DNA Manufacturing Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Plasmid DNA Manufacturing Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Plasmid DNA Manufacturing Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Grade, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Development Phase, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Plasmid DNA Manufacturing Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Lonza
12.2.2. Charles River Laboratories
12.2.3. Thermo Fisher Scientific
12.2.4. AGC Biologics
12.2.5. GenScript ProBio
12.2.6. Aldevron (Danaher)
12.2.7. Cobra Biologics (Charles River)
12.2.8. Catalent
12.2.9. WuXi AppTec
12.2.10. WuXi Advanced Therapies
12.2.11. Eurogentec
12.2.12. Sartorius (BIA Separations)
12.2.13. PharmaCell
12.2.14. ProBio
12.2.15. Pharmaron
12.2.16. Esco Aster
12.2.17. AGTC (Applied Genetic Technologies Corp.)
12.2.18. VGXI (GeneOne Life Science)
12.2.19. PlasmidFactory
12.2.20. VectorBuilder
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PLASMID DNA MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Lonza
- Charles River Laboratories
- Thermo Fisher Scientific
- AGC Biologics
- GenScript ProBio
- Aldevron (Danaher)
- Cobra Biologics (Charles River)
- Catalent
- WuXi AppTec
- WuXi Advanced Therapies
- Eurogentec
- Sartorius (BIA Separations)
- PharmaCell
- ProBio
- Pharmaron
- Esco Aster
- AGTC (Applied Genetic Technologies Corp.)
- VGXI (GeneOne Life Science)
- PlasmidFactory
- VectorBuilder
- Others
GLOBAL PLASMID DNA MANUFACTURING MARKET, BY GRADE- MARKET ANALYSIS, 2020 - 2033
- R&D Grade
- Viral Vector Development
- AAV
- Lentivirus
- Adenovirus
- Retrovirus
- Others
- mRNA Development
- Antibody Development
- DNA Vaccine Development
- Others
- GMP Grade
GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DEVELOPMENT PHASE- MARKET ANALYSIS, 2020 - 2033
- Pre-Clinical Therapeutics
- Marketed Therapeutics
- Clinical Therapeutics
GLOBAL PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- DNA Vaccines
- Immunotherapy
- Cell & Gene Therapy
- Others
GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DISEASE- MARKET ANALYSIS, 2020 - 2033
- Genetic Disorder
- Cancer
- Infectious Disease
- Others
GLOBAL PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
